ENGI-002

N/A

Report date: 2024/06/07 18:14:38

Base Information

Drug NameENGI-002
Drug Alias NameENGI-002ENGI-002 specTR
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionMelanoma-associated antigen 3 modulators
TargetsMelanoma-associated antigen 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEngimmune Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesEngimmune Therapeutics AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A